Evaluation of Hyaluronic Acid in Addition to Xenograft in Immediate Implant Placement Within Maxi… (NCT06783517) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Evaluation of Hyaluronic Acid in Addition to Xenograft in Immediate Implant Placement Within Maxillary Esthetic Zone
Egypt20 participantsStarted 2023-10-30
Plain-language summary
Study design:
The present study will be carried out on twenty patients selected from the department of Oral Medicine, Periodontology, Oral Diagnosis and Radiology, Faculty of Dentistry, Mansoura University for replacement of non restorable maxillary anterior and/or premolar teeth within esthetic zone by immediate implant divided into two groups. A written informed consent will be obtained from all patients before their participation in this study.
Evaluation of study:
All patients will be seen at regular time interval for evaluation at the visit of surgical intervention , follow up of clinical parameter will be recorded monthly then three , six months postoperative and six month after loading(with twelve month follow up study).
1. Clinical evaluation:
Implant stability evaluation Soft tissue evaluation
2. Radiographic evaluation:
* Marginal bone loss(MBL).
Who can participate
Age range
20 Years – 60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* • Patients who are medically free from any systemic diseases.
* Patients with good oral hygiene and regular maintenance.
* Age of patients will be \>20 years.
* Presence of at least single non restorable maxillary anterior and/or premolar tooth due to caries, root resorption, endodontic failure, root fracture or tooth with open apex.
* No acute infection is present within both periodontal and/or peri-apical area within the tooth of concern and/or adjacent teeth.
* Patients with extraction socket type I.
* Free from history of clenching, tapping and bruxism.
* Patients prepared to co-operate and comply with the follow-up and maintenance program.
Exclusion Criteria:
* • Patients taking medications known to influence bone metabolism ( such as heparin, warfarin, corticosteroid).
* Smoking and alcoholic patients.
* History of radiation in the head and neck region.
* Insufficient interocclusal distance for implant placement and restoration.
* Patient with lack of stable posterior occlusion.
* Pregnant, lactating and post-menopausal female patients. Complete medical history, dental history will be taken to all of patients in the study.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
radiographic marginal bone change
Timeframe: preoperative , at time implant placement, six and twelve months after implant placement
2
Implant stability evaluation
Timeframe: at time of placement, three , six months after surgery to assess secondary implant stability